08.12.26 -- Can Oligo Regulations Keep Up With Manufacturing Innovation?

Gain insight into how nebulized mRNA lipid nanoparticles show preclinical success in lung delivery, offering fresh momentum for inhaled gene therapies targeting respiratory diseases.

Explore the benefits of using mRNA for vaccines and therapeutics, and how to address technical, intellectual property, and cost considerations when considering commercial production.

Ensuring consistency and quality at every manufacturing stage is critical for CRISPR-Cas gene editing. To achieve this, the FDA recommends establishing well-defined acceptance criteria for RNP formation.

Metal-sensitive analytes often suffer from poor recovery and distorted peak shapes. Learn how inert hardware improves sensitivity and chromatographic performance for challenging analyses.

As organizations adapt to evolving safety standards for mRNA, collaboration remains essential to navigate challenges such as regional requirements, dosing needs, and analytical complexities.

This partnership with SCC launched a biomanufacturing program, building career pathways and community talent for Spokane’s growing life sciences and pharmaceutical manufacturing sector.

mRNA has emerged as a promising modality offering a great deal of versatility for a wide range of therapeutics and vaccines with its use of non-viral delivery systems.

Stay ahead in mRNA therapeutic development by mastering the essential quality systems, process controls, and analytical methods required for robust GMP production and efficient manufacturing.